|
Corporate News
29-Nov-22
|
|
|
|
|
|
|
Gland Pharma enters into put option agreement to acquire 100% of Cenexi Group
|
|
|
|
Gland Pharma announced that it has through its wholly owned subsidiary Gland Pharma International, Singapore entered into a Put Option Agreement to acquire 100% of Cenexi Group for an Equity Value not
exceeding Euro 120 Mn (Enterprise Value of Euro 230 Mn).
Founded in 2004, Cenexi, along with its Subsidiaries, is engaged primarily in the business of Contract Development & Manufacturing Organisation (CDMO) of pharmaceutical products with expertise in sterile liquid and lyophilized fill finished drug, including capabilities on oncology and complex products. It has presence across four manufacturing
sites in Europe which include three sites in France and one site in Belgium. It has experience in processing specific substances like hormones, suspensions and controlled substances. It has an employee strength of 1,372 including 1,252 employees across 4 manufacturing sites and 120 employees for services. Its revenue for CY21 stood at Euro
184.1 Mn.
Gland Pharma has a strategic focus on expanding its CDMO offerings in the European market and build a manufacturing presence in the market. The acquisition provides Gland Pharma access to leading know-how and
development capabilities in sterile forms including for ophthalmic gel, needleless injectors and hormones. Gland Pharma's ability to support future investments in expanding manufacturing footprint will help build Cenexi as a major CDMO player in the European market. Gland and Cenexi can leverage their long- standing customer relationships to
generate synergistic benefit for both entities along with helping Gland enter the branded CDMO space.
|
|
Previous News |
Gland Pharma receives USFDA approval for Eribulin Mesylate Injection
(
Corporate News
-
06-Apr-24
17:40
)
|
|
Volumes spurt at Krishna Institute of Medical Sciences Ltd counter
(
Hot Pursuit
-
08-Aug-23
14:30
)
|
|
Gland Pharma Ltd gains for fifth session
(
Hot Pursuit
-
05-Feb-24
13:00
)
|
|
Gland Pharma to hold board meeting
(
Corporate News
-
05-Apr-22
12:12
)
|
|
Gland Pharma IPO subscribed over two times
(
IPO Centre
-
IPO News
11-Nov-20
17:25
)
|
|
Board of Gland Pharma recommends final dividend
(
Corporate News
-
23-May-24
09:38
)
|
|
Gland Pharma allots 64,700 equity shares under ESOS
(
Corporate News
-
07-Oct-21
21:06
)
|
|
Gland Pharma Ltd up for third straight session
(
Hot Pursuit
-
17-Jul-23
13:05
)
|
|
Gland Pharma to hold AGM
(
Corporate News
-
23-May-24
09:38
)
|
|
Volumes jump at Gland Pharma Ltd counter
(
Hot Pursuit
-
23-May-24
11:00
)
|
|
Gland Pharma
(
Results
-
Analysis
27-Oct-22
10:43
)
|
|
|
|
Other Stories |
|
|
|
|
|
|
|
|